Abstract
HIV-1 resistance towards integrase inhibitors is a potential threat of the success of HIV-1 combination treatment. G118R is a rare drug resistance mutation conferring pan-integrase resistance. Here, we describe the occurrence of G118R in a HIV-1 subtype-B-positive individual with major compliance problems, detected while the patient was on dolutegravir-based cART. We speculate the pre-selection of M184I/V aided the occurrence of G118R in this case, and discuss the robustness of dolutegravir-based therapies.
| Original language | English |
|---|---|
| Journal | Infectious disease reports |
| Volume | 14 |
| Issue number | 4 |
| Pages (from-to) | 501-504 |
| Number of pages | 4 |
| ISSN | 2036-7430 |
| DOIs | |
| Publication status | Published - 22 Jun 2022 |
Keywords
- HIV-1
- drug resistance
- integrase inhibitors
Fingerprint
Dive into the research topics of 'Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS